Nescient helix-loop-helix protein 1 (NHLH1)

Nescient helix-loop-helix protein 1 (NHLH1) is a DNA-binding transcription factor belonging to the basic helix-loop-helix (bHLH) protein family, encoded by the NHLH1 gene in humans[1][4]. It plays a key role in the determination of cell fate, particularly within the developing nervous system, acting as a regulator of neural differentiation[2][4][5]. NHLH1 is expressed in differentiating cells, especially olfactory and vomeronasal sensory neurons[5]. Its expression is upregulated by transcription factors such as ATF5 and Lhx2[5]. NHLH1 functions via sequence-specific DNA binding and protein dimerization, enabling the activation of RNA polymerase II-dependent transcription required for cell-type specification[2][4]. Disease associations include congenital disorders affecting craniofacial development and indirect links to tumorigenesis through its protein family[1][4][7]. NHLH1 interacts with several proteins, including CSRP3, LMO family members, and others involved in protein binding and transcriptional regulation[2][7]. No approved drugs currently target NHLH1 directly nor are there established clinical biomarkers or mechanisms of action for drug targeting. As a transcription factor, NHLH1 is not a cell-surface receptor, channel, enzyme, or transporter but is classified within core molecular regulators of gene expression and development[1][2][4].

Other names

Helix-loop-helix protein 1NHLH1BHLHA35HEN1HEN-1bHLHa35NSCL-1NSCLNSCL1class A basic helix-loop-helix protein 35

Not applicable or unavailable; no drugs are established to target NHLH1 directly.